OSIRIS THERAPEUTICS INC NEW's ticker is and the CUSIP is 68827R908. A total of 2 filers reported holding OSIRIS THERAPEUTICS INC NEW in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $163,000 | +365.7% | 33,100 | +366.2% | 0.00% | – |
| Q3 2016 | $35,000 | -62.4% | 7,100 | -61.2% | 0.00% | -100.0% |
| Q2 2016 | $93,000 | -38.4% | 18,300 | -30.7% | 0.00% | -50.0% |
| Q1 2016 | $151,000 | +331.4% | 26,400 | +676.5% | 0.00% | – |
| Q4 2015 | $35,000 | -16.7% | 3,400 | +47.8% | 0.00% | -100.0% |
| Q3 2015 | $42,000 | -2.3% | 2,300 | +4.5% | 0.00% | 0.0% |
| Q2 2015 | $43,000 | -52.2% | 2,200 | -56.9% | 0.00% | 0.0% |
| Q1 2015 | $90,000 | +210.3% | 5,100 | +183.3% | 0.00% | – |
| Q4 2014 | $29,000 | +163.6% | 1,800 | +100.0% | 0.00% | – |
| Q3 2014 | $11,000 | -93.9% | 900 | -92.2% | 0.00% | -100.0% |
| Q2 2014 | $181,000 | -78.0% | 11,600 | -81.5% | 0.00% | -78.6% |
| Q1 2014 | $823,000 | -22.4% | 62,700 | -4.9% | 0.01% | -12.5% |
| Q4 2013 | $1,060,000 | +87.3% | 65,900 | +93.8% | 0.02% | +45.5% |
| Q3 2013 | $566,000 | +265.2% | 34,000 | +120.8% | 0.01% | +175.0% |
| Q2 2013 | $155,000 | – | 15,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Citadel Advisors | 4,200 | $67,000 | 0.00% |
| GROUP ONE TRADING, L.P. | 1,800 | $29,000 | 0.00% |